“…These data are in open contrast with the data from other southern countries where HCV prevalence among OLP patients was as high as 25.7% (Italy) [6,8,29,41,54,55,57], 19.1% (Spain) [25,39,40,56] and 5.8% (Turkey) [35,37,42,44,48,49], respectively. Such HCV prevalence values are higher than the values reported for the general population in these countries, which range between 1 and 2.5% [11].…”